- Home
- OB vs SANA Comparison
OB vs SANA Comparison
Compare OB & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OB
- SANA
- Stock Information
- Founded
- OB 2006
- SANA 2018
- Country
- OB United States
- SANA United States
- Employees
- OB N/A
- SANA N/A
- Industry
- OB Industrial Machinery/Components
- SANA Medicinal Chemicals and Botanical Products
- Sector
- OB Industrials
- SANA Health Care
- Exchange
- OB Nasdaq
- SANA Nasdaq
- Market Cap
- OB 441.8M
- SANA 522.4M
- IPO Year
- OB 2021
- SANA 2021
- Fundamental
- Price
- OB $4.02
- SANA $2.92
- Analyst Decision
- OB Buy
- SANA Strong Buy
- Analyst Count
- OB 6
- SANA 4
- Target Price
- OB $6.80
- SANA $13.00
- AVG Volume (30 Days)
- OB 501.3K
- SANA 2.6M
- Earning Date
- OB 02-27-2025
- SANA 05-07-2025
- Dividend Yield
- OB N/A
- SANA N/A
- EPS Growth
- OB N/A
- SANA N/A
- EPS
- OB N/A
- SANA N/A
- Revenue
- OB $889,875,000.00
- SANA N/A
- Revenue This Year
- OB $30.47
- SANA N/A
- Revenue Next Year
- OB N/A
- SANA N/A
- P/E Ratio
- OB N/A
- SANA N/A
- Revenue Growth
- OB N/A
- SANA N/A
- 52 Week Low
- OB $3.58
- SANA $1.52
- 52 Week High
- OB $7.87
- SANA $10.50
- Technical
- Relative Strength Index (RSI)
- OB 23.52
- SANA 54.57
- Support Level
- OB $3.89
- SANA $2.49
- Resistance Level
- OB $4.41
- SANA $2.67
- Average True Range (ATR)
- OB 0.41
- SANA 0.21
- MACD
- OB -0.16
- SANA 0.01
- Stochastic Oscillator
- OB 4.78
- SANA 72.73
About OB Outbrain Inc.
Outbrain Inc is a platform powering the open web that matches audiences with personalized content and ads, driving quality engagement. Its platform delivers ads to end-users that appear as links to articles, products, and videos on media partners' sites. It derives revenue from advertisers through user engagement with the ads that it places on media partners' web pages and mobile applications. The company has its geographic presence in Europe, the Middle East, and Africa followed by the USA and others.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.